DermoSafe

Lausanne, Switzerland Founded: 2012 • Age: 14 yrs
Offers imaging devices and software for accurate diagnostic purposes.

About DermoSafe

DermoSafe is a company based in Lausanne (Switzerland) founded in 2012 by Philippe Held. It operates as a B2B. DermoSafe operates in a competitive market with competitors including Castle Biosciences, DermTech, AMLo Biosciences, Haut and Veriskin, among others.

  • Headquarter Lausanne, Switzerland
  • Founders Philippe Held
  • Sectors
    Healthcare
  • Website dermosafe.com
  • Social Facebook
Operational Areas
Key Metrics

Funding Insights of DermoSafe

  • Total Rounds 1
  • Last Round Grant β€” $56,595
  • First Round $56,595

    (Dec 2018)

  • Investors Count 1

All 1 funding rounds of DermoSafe with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2018$56,595Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in DermoSafe

DermoSafe has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for DermoSafe

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of DermoSafe

1 people are tracked at DermoSafe (1 in leadership).

NameRoleGroup
Philippe Held
Founder, CEOLeadership
Premium access

Complete people profiles for DermoSafe

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of DermoSafe

2 dated milestones of DermoSafe across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded DermoSafe is founded.
  2. Funding First funding round of $57K.

Competitors of DermoSafe

DermoSafe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, AMLo Biosciences, Haut and Veriskin, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cernostics.com2008Pittsburgh, United States$14.18M16
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
dermtech.com1996San Diego, United States$24.37M259
Adhesive patch biopsies for skin cancer detection are provided.
amlo-biosciences.com2017Newcastle Upon Tyne, United Kingdom$7.69M11
Prognostic tests for early-stage melanoma detection are developed.
haut.ai2017Tallinn, Estonia$2.15M4
SaaS solutions using AI for skincare businesses are provided.
veriskin.com2014San Diego, United States$1.68M–
Tools for non-invasive skin cancer diagnosis are developed.
melagenix.info2017Cologne, Germany$8.92M–
Molecular diagnostic tests for skin cancer detection are developed.
michelsondiagnostics.com2006Maidstone, United Kingdom$14.87M11
Develops and supplies VivoSight OCT scanners for non-invasive medical diagnostics.
chowis.com2012–––
Offers AI tools for skin and hair analysis to recommend products effectively.
eykona.com2007Oxford, United Kingdom$1.86M–
Portable 3D imaging systems for dermatological applications are provided.
verisante.com2006Vancouver, Canada–2
Diagnostic devices for early cancer detection are developed and commercialized.
Premium access

Detailed competitors of DermoSafe

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to DermoSafe

10 companies that operate in the same segment as DermoSafe (Imaging Diagnostics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Handheld ultrasound devices are developed for whole-body medical imaging.
2011Guilford, Connecticut, United StatesUSD 350 MUSD 97.61 M190
Technology tools and systems for molecular scale are developed.
1959Abingdon, Oxfordshire, United Kingdom–USD 648.1 M–
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.17 M–242
Manufacturer of imaging and surgical products
1919Tokyo, Tokyo, Japan–USD 6.49 B35,933
Ultrasound images are analyzed via AI-based software provided by Exo.
2015Redwood City, California, United StatesUSD 463.39 M––
Planar X-ray radiology products for diagnostic imaging are supplied.
2000Oxford, Oxfordshire, United KingdomUSD 43.43 MUSD 1.04 M50
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
2004Jerusalem, Jerusalem District, IsraelUSD 110.72 MUSD 13.02 M165
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
2007Los Angeles, California, United StatesUSD 59.64 M––
Portable wireless ultrasound systems are developed for medical imaging.
2014Burnaby, British Columbia, CanadaUSD 21.87 M––
Portable MRI systems are manufactured for medical professionals.
2014New York, New York, United States–USD 13.56 M111
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DermoSafe

DermoSafe was founded in 2012 and raised its 1st funding round 6 years after it was founded.

DermoSafe is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.

Philippe Held is the current CEO of DermoSafe. They have also founded this company.

DermoSafe, based in Lausanne, focuses on providing healthcare solutions, developing medical devices, diagnostic imaging, and providing software for education. Offers imaging devices and software for accurate diagnostic purposes. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

DermoSafe's top competitors include DermTech, AMLo Biosciences and Castle Biosciences.

DermoSafe has 1 investor. Key investors include European Union.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available